EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gut microbiota-generated trimethylamine N-oxide from dietary choline and vascular function in humans

Eleni Laskaridou, Cortney N. Steele, Glen R. Reid, Janet T. Rinehart, Elaina L. Marinik, Kristen R. Howard, Bailey T. Capra, Brenda M. Davy, Michael G. Sweet, Andrew P. Neilson, Kevin P. Davy

The Journal of Nutritional Physiology · 2025

DOI: 10.1016/j.jnphys.2025.100009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Nutritional Physiology, 2025. Verfasst von Eleni Laskaridou und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health, National Institute on Aging.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated concentrations of the gut microbiota-generated metabolite, trimethylamine N-oxide (TMAO), has been causally linked to cardiovascular disease in preclinical studies. Whether TMAO contributes to impairments in vascular function in healthy humans remains unknown. We hypothesized that increases in TMAO will impair endothelial function and arterial stiffness. In double-blind, placebo-controlled, crossover studies participants consumed a 1000 mg dose of choline bitartrate or placebo (maltodextrin) either the night before each testing session (acute study) or daily for 4 weeks (short-term study). Flow-mediated dilation (FMD) and arterial stiffness were measured the morning following evening dosing (∼12 h) in the acute study and before and following the short-term study. Plasma TMAO concentrations increased in both the acute and chronic studies. (acute: p = 0.001, short-term: p = 0.02). However, there were no differences in FMD (7.9 ± 2.8 % vs. 8.4 ± 2.4 %, P = 0.0073, respectively), arterial stiffness, or blood pressure between placebo and choline following acute increases in plasma TMAO concentrations in the pooled sample (all P > 0.05). Similarly, there was no significant changes in FMD (pre-choline: 9.3 ± 2.8, post-choline: 9.5 ± 2.7 %), arterial stiffness, or blood pressure in either placebo or choline following increases in plasma TMAO concentrations after 4 weeks. In an exploratory analysis, we observed a transient increase in FMD in men compared with women in response to gut microbiota-generated increases in TMAO acutely but not short-term. More research is needed to explore the nature of the association between elevated TMAO concentrations and CVD.

Förderung

  • National Institutes of Health
  • National Institute on Aging

Zitieren

APA

Laskaridou, E., Steele, C. N., Reid, G. R., Rinehart, J. T., Marinik, E. L., Howard, K. R., Capra, B. T., Davy, B. M., Sweet, M. G., Neilson, A. P., & Davy, K. P. (2025). Gut microbiota-generated trimethylamine N-oxide from dietary choline and vascular function in humans. The Journal of Nutritional Physiology. https://doi.org/10.1016/j.jnphys.2025.100009

Vancouver

Laskaridou E, Steele CN, Reid GR, Rinehart JT, Marinik EL, Howard KR, et al. Gut microbiota-generated trimethylamine N-oxide from dietary choline and vascular function in humans. The Journal of Nutritional Physiology. 2025. doi:10.1016/j.jnphys.2025.100009

BibTeX
@article{Laskaridou2025,
  author = {Laskaridou, Eleni and Steele, Cortney N. and Reid, Glen R. and Rinehart, Janet T. and Marinik, Elaina L. and Howard, Kristen R. and Capra, Bailey T. and Davy, Brenda M. and Sweet, Michael G. and Neilson, Andrew P. and Davy, Kevin P.},
  title = {Gut microbiota-generated trimethylamine N-oxide from dietary choline and vascular function in humans},
  journal = {The Journal of Nutritional Physiology},
  year = {2025},
  doi = {10.1016/j.jnphys.2025.100009}
}
Kostenlos starten →